1. Cerebral venous thrombosis in Behçet’s disease: a systematic review

   • D. Aguiar de Sousa
   • T. Mestre
   • J. M. Ferro

   Review 06 January 2011 Pages: 719 - 727

2. Managing MS in a changing treatment landscape

   • Martin Duddy
   • Aiden Haghikia
   • Ralf Gold

   Review 25 March 2011 Pages: 728 - 739

   

3. Lateral trunk flexion in Parkinson’s disease: EMG features disclose two different underlying pathophysiological mechanisms

   • Alessandro Di Matteo
   • Alfonso Fasano
   • Michele Tinazzi

   Original Communication 16 November 2010 Pages: 740 - 745

   

4. Comparison of muscle ultrastructure in myasthenia gravis with anti-MuSK and anti-AChR antibodies

   • Giovanna Cenacchi
   • Papa Valentina
   • Angelini Corrado

   Original Communication 19 November 2010 Pages: 746 - 752

   

5. Influence of CagA-positive Helicobacter pylori strains on atherosclerotic carotid disease

   • Petra Bago Rožanković
   • Arijana Lovrenčić Huzjan
   • Vida Demarin

   Original Communication 18 November 2010 Pages: 753 - 761

   

6. Monitoring systemic oxidative stress in an animal model of amyotrophic lateral sclerosis

   • Francisco Javier Miana-Mena
   • Cristina González-Mingot
   • Joaquín José García

   Original Communication 25 November 2010 Pages: 762 - 769

   

7. Congenital prosopagnosia: multistage anatomical and functional deficits in face processing circuitry

   • V. Dinkelacker
   • M. Grüter
   • G. Fernandez

   Original Communication Open access 01 December 2010 Pages: 770 - 782

   

8. Clinical relevance and neurophysiological correlates of spasticity in cerebrotendinous xanthomatosis

   • A. Mignarri
   • S. Rossi
   • M. T. Dotti

   Original Communication 21 November 2010 Pages: 783 - 790

9. Improvement of exhausted cerebral vasoreactivity in carotid occlusion: benefit of statins?

   • Matthias Reinhard
   • Brigitte Guschlbauer
   • Andreas Hetzel

   Original Communication 30 November 2010 Pages: 791 - 794

   

10. Design, data management, and population baseline characteristics of the PERFORM magnetic resonance imaging project

    • P. Maeder
    • L. Bracoud
    • M. Hennerici

    Original Communication Open access 03 December 2010 Pages: 795 - 803

    

11. Patterns of cortical activity differ in ALS patients with limb and/or bulbar involvement depending on motor tasks

    • Katja Kollewe
    • Thomas F. Münte
    • Bahram Mohammadi

    Original Communication 03 December 2010 Pages: 804 - 810

    

12. Occurrence of neuronal dysfunction during the first 5 years of multiple sclerosis is associated with cognitive deterioration

    • Wafaa Zaaraoui
    • Françoise Reuter
    • Bertrand Audoin

    Original Communication 04 December 2010 Pages: 811 - 819

    

13. Is the midbrain involved in the manifestation of gait disturbance in idiopathic normal-pressure hydrocephalus?

    • Kotaro Hiraoka
    • Hiroshi Yamasaki
    • Etsuro Mori

    Original Communication 04 December 2010 Pages: 820 - 825

    

14. Does the clinical practice guideline on Parkinson’s disease change health outcomes? A cluster randomized controlled trial

    • Astrid Larisch
    • Alexander Reuss
    • Karla Eggert

    Original Communication 07 December 2010 Pages: 826 - 834

    

15. Impact of fatigue on the efficacy of rehabilitation in multiple sclerosis

    • Elda Judica
    • Filippo Martinelli Boneschi
    • Paolo Rossi

    Original Communication 15 January 2011 Pages: 835 - 839

    

16. EEG low-resolution brain electromagnetic tomography (LORETA) in Huntington’s disease

    • Annamaria Painold
    • Peter Anderer
    • Raphael M. Bonelli

    Original Communication 12 December 2010 Pages: 840 - 854

    

17. Diagnostic accuracy of acute vestibular syndrome at the bedside in a stroke unit

    • L. Chen
    • W. Lee
    • H. M. Dewey

    Original Communication 12 December 2010 Pages: 855 - 861

18. Aneurysmal and clinical characteristics as risk factors for intracerebral haematoma from aneurysmal rupture

    • Xiaomeng Liu
    • Gabriel J. E. Rinkel

    Original Communication Open access 14 December 2010 Pages: 862 - 865

19. Camptocormia phenotype of FSHD: a clinical and MRI study on six patients

    • Berit Jordan
    • Katharina Eger
    • Stephan Zierz

    Original Communications 17 December 2010 Pages: 866 - 873

    

20. A randomised controlled trial of treatment for idiopathic intracranial hypertension

    • Alexandra K. Ball
    • Andrew Howman
    • Carl E. Clarke

    Original Communication 16 December 2010 Pages: 874 - 881

    

21. Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis

    • M. Axelsson
    • C. Malmeström
    • J. Lycke

    Original Communication 01 January 2011 Pages: 882 - 888

    

22. Assessment of gait parameters and fatigue in MS patients during inpatient rehabilitation: a pilot trial

    • Rosaria Sacco
    • Rita Bussman
    • Serafin Beer

    Original Communication 15 November 2010 Pages: 889 - 894

23. One-year evaluation of factors affecting the biological activity of interferon beta in multiple sclerosis patients

    • Simona Malucchi
    • Francesca Gilli
    • Antonio Bertolotto

    Original Communication 12 December 2010 Pages: 895 - 903

    

24. Neutralizing antibodies in interferon beta treated patients with multiple sclerosis: knowing what to do now

    • Til Menge
    • Hans-Peter Hartung
    • Bernd C. Kieseier

    Short Commentary 22 February 2011 Pages: 904 - 907

    

25. Response to comment on “Cerebral venous thrombosis in Behcet’s disease: a systematic review” by Afshin Borhani-Haghighi and Anahid Safari

    • Diana Aguiar de Sousa
    • Tiago Mestre
    • José Ferro

    Short Commentary 15 March 2011 Pages: 908 - 909

26. Comment on “cerebral venous thrombosis in Behcet’s disease: a systematic review”

    • Afshin Borhani-Haghighi
    • Anahid Safari

    Short Commentary 08 March 2011 Pages: 910 - 911

27. Carotid dissection in mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes

    • Robin C. C. Ryther
    • Yoon Andrew Cho-Park
    • Jong Woo Lee

    Letter to the editors 13 November 2010 Pages: 912 - 914

    

28. Progressive external ophthalmoplegia as initial manifestation of sporadic late-onset nemaline myopathy

    • Oliver Wengert
    • Andreas Meisel
    • Werner Stenzel

    Letter to the Editors 12 November 2010 Pages: 915 - 917

    

29. Late-stage Parkinson’s disease in the Lisbon-Barcelona cohorts: past phenomenology and today’s clinical needs

    • S. G. Echebarria

    Letter to the Editors 18 November 2010 Pages: 918 - 919

30. Reply to: Late-stage Parkinson’s disease: the Barcelona and Lisbon cohorts. Past phenomenology and today’s clinical needs

    • Miguel Coelho

    Letter to the editors 19 November 2010 Pages: 920 - 920

31. Brainstem and spinal cord involvement in a paraneoplastic syndrome associated with anti-Yo antibody and breast cancer

    • Domenico Plantone
    • Pietro Caliandro
    • Anna Paola Batocchi

    Letter to the Editors 17 November 2010 Pages: 921 - 922

32. Hemifacial presentation of mitochondrial myopathy

    • Nadeem Ali
    • James Acheson

    Letter to the Editors 26 January 2011 Pages: 923 - 924

    

33. The diagnostic conundrum of primary angiitis of the central nervous system: a case report

    • Dipender Gill
    • Stephan Hinze
    • Jacqueline Palace

    Letter to the Editors 23 November 2010 Pages: 925 - 928

    

34. Homology between Klebsiella pneumoniae and human aquaporin-4: no evidence for cross-reactivity in neuromyelitis optica. A study on 114 patients

    • S. Jarius
    • K. P. Wandinger
    • B. Wildemann

    Letter to the Editors 02 December 2010 Pages: 929 - 931

    

35. Susceptibility weighted imaging: does it give information similar to perfusion weighted imaging in acute stroke?

    • C. Kesavadas
    • B. Thomas
    • P. N. Sylaja

    Letter to the Editors 30 November 2010 Pages: 932 - 934

    

36. MS-like presentation of Alexander disease with multifocal lesions and oligoclonal bands

    • Henriette J. Tschampa
    • Susanne Greschus
    • Wanda M. Gerding

    Letter to the Editors 04 December 2010 Pages: 935 - 937

    

37. Late onset Alexander’s disease presenting as cerebellar ataxia associated with a novel mutation in the GFAP gene

    • Stephan Schmidt
    • Mike P. Wattjes
    • Marjo van der Knaap

    Letter to the Editors 17 December 2010 Pages: 938 - 940

    

38. A urinary cause of coma

    • Nicolas Weiss
    • Charlene Levi
    • Jean-Luc Diehl

    Letter to the Editors 07 December 2010 Pages: 941 - 943

    

39. EBV related cerebral lymphoma in a leukemia patient treated with alemtuzumab

    • B. van de Langerijt
    • J. K. Doorduijn
    • M. J. van den Bent

    Letter to the Editors Open access 07 December 2010 Pages: 944 - 945

    

40. Long-term efficiency of intravenously administered immunoglobulin in anti-Yo syndrome with paraneoplastic cerebellar degeneration

    • J. Schessl
    • M. Schuberth
    • B. Schoser

    Letter to the Editors 21 December 2010 Pages: 946 - 947

    

41. Striatal 123I-Ioflupane SPECT abnormality in sporadic Creutzfeldt–Jakob disease

    • Claire Hinnell
    • Muriel Buxton-Thomas
    • Michael Samuel

    Letter to the Editors 21 December 2010 Pages: 948 - 950

    

42. Édouard Brissaud (1852–1909)

    • Jacques Poirier

    Pioneers in Neurology 17 December 2010 Pages: 951 - 952

    

43. Erratum to: Comparison of muscle ultrastructure in myasthenia gravis with anti-MuSK and anti-AChR antibodies

    • Giovanna Cenacchi
    • Valentina Papa
    • Corrado Angelini

    Erratum 11 January 2011 Pages: 953 - 953

44. Multiple sclerosis II: new diagnostic criteria, association with smoking and effects of cannabis on cognitive function

    • Michael Strupp

    Journal Club 22 April 2011 Pages: 954 - 957

45. Communications of the European Neurological Society

    ENS Communications 16 April 2011 Pages: 958 - 959